BRAND_ANALYSIS#PFIZERHEALTH & PHARMA#24 OF 26 IN HEALTH & PHARMAALIGNED
Pfizer
· Public · Updated 22 Nov 2026 07:19 UTC
#1107 of 1208 overall by tension · #24 of 26 in Health & Pharma
7Aligned
The Balanced
Analysis
Pfizer holds C50 / B57 with an 8.61 percent stock fall, a pharmaceutical giant whose cultural reputation still carries pandemic-era baggage. The business is sturdy but the public story is unresolved. Tension remains modest, which says the company is less fought over than it used to be.
IN THE NEWS (100 articles this week)
Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna - Fierce Biotech
Pfizer licenses CAR-T therapies from China's Starna in up to $2.6 billion deal - Reuters